Exobiosphere

Exobiosphere provides an Orbital High-Throughput System that enables large-scale, automated drug testing and disease modeling in microgravity. The company facilitates target identification, drug development, and disease phenotyping for therapeutic areas including oncology, neurodegeneration, and cardiovascular health. Its services bridge the gap between laboratory research and clinical applications for pharmaceutical and biotech partners.